суббота, 25 февраля 2017 г.

3 Biotech Long Shots: Boom Or Bust?

3 Biotech Long Shots: Boom Or Bust?


However, success may be tough to come by, and that makes investing in these stocks a boom or bust proposition. Axovant is trying to do something that most biopharma companies have failed to accomplish: develop a new Alzheimer's disease drug.



from Biotech News